Undecimal Bio
Undecimal pairs massive scale combinatorial chemistry with transformer-based AI to guide siRNA therapeutics into the tissues that need them.
$18M Seed ·
Source: allsci.com
Funding history ↓About Undecimal Bio
Undecimal Bio is a company based in Ramat Gan, Israel. Recent Funding lists it under Health and bio. It raised $18M in a Seed round in October 2026, according to allsci.com. Investors on record include 4BIO Capital, Entrée Capital, Harel Insurance and Financial, IQ Capital and 3 others. It was founded by Yaniv Erlich and Shaul Ilan.
Funding rounds
- Seed · $18MSource: allsci.com
- Website created
Founders and team
YE
Yaniv Erlich Co-founder and CEOsource: undecimalbio.comSI
Shaul Ilan Co-founder and COOsource: undecimalbio.com
Investors
44BIO Capital
EEntrée Capital
HHarel Insurance and Financial
IIQ Capital
KKerna Ventures
SSaras Capital
VVerve Ventures
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Undecimal Bio: questions and answers
- How much has Undecimal Bio raised?
- Undecimal Bio has raised $18M in one sourced round on record (Seed), announced October 13, 2026.
- Who invested in Undecimal Bio?
- Investors on record for Undecimal Bio: 4BIO Capital, Entrée Capital, Harel Insurance and Financial, IQ Capital, Kerna Ventures, Saras Capital and Verve Ventures.
- Who founded Undecimal Bio?
- Undecimal Bio was founded by Yaniv Erlich (Co-founder and CEO) and Shaul Ilan (Co-founder and COO).
- Where is Undecimal Bio based?
- Undecimal Bio is based in Ramat Gan, Israel.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/undecimal-bio (get a free API key).